Saturday 17 October 2026 Export PDSB’s income statement to Excel — free account

PDS Biotechnology Corporation

In the quarter to June 2026, EPS grew 14.3%, free cash flow grew 69.3% and total debt fell 66.6%, each against the same quarter a year earlier.

1.13 0.17 −13.08%

Follow PDSB

Alert me

Market cap: $72.8M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(543.97%)	(254.09%)	(244.16%)	(221.81%)	+8 more TTM periods Free account
ROA Full definition →	(136.65%)	(93.05%)	(90.95%)	(80.05%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	653.10%	(259.50%)	(182.60%)	(237.49%)
Free Cash Flow per Share Full definition →	(0.30)	(0.42)	(0.60)	(0.69)
Free Cash Flow Full definition →	(16.78)	(23.09)	(27.75)	(32.28)
Other line items
Cash ROIC Full definition →	(264.35%)	(63.83%)	(52.51%)	(67.86%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →	(4.18)	(5.34)	(5.91)	(6.06)
Operating CF/Net income Full definition →	0.50	0.69	0.80	0.93
Depreciation/Fixed assets Full definition →	5.33	15.61	13.43	11.45
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.30)	(0.42)	(0.60)	(0.69)
Capex per Share Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly